CureVac to Present at the 19th Annual Piper Jaffray Healthcare Conference

TÜBINGEN, Germany / BOSTON, MA, November 21, 2018 – CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 19th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 27, 2018 at 10:50 a.m. ET.

A live audio broadcast of the presentation will be available at www.curevac.com/en/newsroom/curevacevents. An archived replay of the presentation will be available on the company’s website for 3 months following the presentation.

Download press release as PDF file.